Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Expert Opinion on Pharmacotherapy
|
October 27, 2004
Efficacy and safety of ibandronate in the treatment of neoplastic bone disease
Martin Pecherstorfer
Expert Opinion on Pharmacotherapy
|
November 14, 2008
Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update
Martin Pecherstorfer
Women'S Health (London, England)
|
February 28, 2009
Treatment options for breast cancer and bone metastases
Martin Pecherstorfer
Expert Opinion on Pharmacotherapy
|
June 13, 2017
Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma
Klaus Podar, Martin Pecherstorfer
Wiener Medizinische Wochenschrift (1946)
|
January 24, 2009
[Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care]
Dora Beke, Martin Pecherstorfer
Treatments in Endocrinology
|
June 22, 2005
Current management strategies for hypercalcemia
Martin Pecherstorfer, Karin Brenner, Niklas Zojer
Expert Opinion on Biological Therapy
|
September 1, 2017
Adoptive cell therapy in multiple Myeloma
Sonia Vallet, Martin Pecherstorfer, Klaus Podar
Wiener Medizinische Wochenschrift (1946)
|
September 19, 2017
Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature
Matthäus Strieder, Martin Pecherstorfer, Gudrun Kreye
Frontiers in Oncology
|
January 11, 2020
Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives
Hannes Zwickl, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Leukemia & Lymphoma
|
February 23, 2016
A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone
Hannes Zwickl, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Expert Opinion on Pharmacotherapy
|
October 27, 2004
Efficacy and safety of ibandronate in the treatment of neoplastic bone disease
Martin Pecherstorfer
Expert Opinion on Pharmacotherapy
|
November 14, 2008
Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update
Martin Pecherstorfer
Women'S Health (London, England)
|
February 28, 2009
Treatment options for breast cancer and bone metastases
Martin Pecherstorfer
Expert Opinion on Pharmacotherapy
|
June 13, 2017
Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma
Klaus Podar, Martin Pecherstorfer
Wiener Medizinische Wochenschrift (1946)
|
January 24, 2009
[Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care]
Dora Beke, Martin Pecherstorfer
Treatments in Endocrinology
|
June 22, 2005
Current management strategies for hypercalcemia
Martin Pecherstorfer, Karin Brenner, Niklas Zojer
Expert Opinion on Biological Therapy
|
September 1, 2017
Adoptive cell therapy in multiple Myeloma
Sonia Vallet, Martin Pecherstorfer, Klaus Podar
Wiener Medizinische Wochenschrift (1946)
|
September 19, 2017
Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature
Matthäus Strieder, Martin Pecherstorfer, Gudrun Kreye
Frontiers in Oncology
|
January 11, 2020
Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives
Hannes Zwickl, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Leukemia & Lymphoma
|
February 23, 2016
A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone
Hannes Zwickl, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Page
of 5